Pioneering cancer advancements - PathWest's collaborative initiatives on World Cancer Day
PathWest Molecular Tumour Board
05/02/2024
World Cancer Day, observed annually on 4 February, serves as a reminder of the global collaboration essential in the ongoing battle against cancer.
At the forefront of this collaborative effort is the PathWest Community Health and Hospital Program, spearheading a $19 million initiative in Western Australia dedicated to Comprehensive Genomic Profiling (CGP) for all cancer patients. This ground-breaking endeavour leverages state-of-the-art massively parallel sequencing technology, marking a significant stride in the pursuit of advanced cancer diagnosis and treatment.
CGP is an integral aspect of the program which serves as a transformative tool that identifies biomarkers, guiding tailored treatment strategies and instilling hope for those facing exhaustive conventional treatment options. The program's commitment extends to ensuring equitable cancer care for all Western Australian patients, regardless of their geographical location.
A cornerstone of this initiative is the establishment of the Molecular Tumour Board (MTB), a collective forum where a group of experts, including pathologists, scientists, oncologists, clinicians, geneticists, pharmacists, and researchers gather to discuss and analyse genomic profiling results and match the results to available therapies. This collaborative effort at the MTB ensures informed decision-making, fostering a climate of knowledge exchange that contributes to continuous enhancements in patient care.
On World Cancer Day, the PathWest program stands as a beacon of global collaboration, driving forward the frontier of cancer care through the combination of comprehensive genomic testing, equitable access, and the implementation of an active Molecular Tumour Board.
Let us collectively celebrate these pioneering innovations, offering hope and tangible progress in the ongoing global fight against cancer.
Last Updated:
28/05/2024